News

WEAKID PROGRESS MEETING 5-6 February 2018
The progress meeting was held again in Brussels. During this meeting the following topics have been discussed:
- Update device development, presentation prototypes daytime device (wearable) and nighttime device (portable)
Results of preclinical testing
Overall progress and planning of the project
Joined meeting with the Medical Advisory Board (MAB) and Ethics Board (EB)
Meeting with the EU project officer, adjusted project planning


Consortium members in Hotel Bloom (Brussels)
WEAKID daytime and nighttime device

WEAKID PROGRESS MEETING 19-20 October 2017
This progress meeting was held in Brussels. Main purpose of the meeting was to discuss the  biocompatibility and efficay of the system. Based on new results from extended viability and wound closure capacity tests of mesothelial cells, some modifications have been proposed and discussed. Next to a wearable system for daytime use, an extended, portable version for nighttime use will be applied and evaluated in the clinical trials.  


WEAKID PROGRESS MEETING 2th June 2017
The first progress meeting of WEAKID was held in Madrid at the premises of IdiPAZ in conjunction with the ERA-EDTA conference on June 2th 2017. An update was given on the WEAKID device by Nanodialysis and the projected planning of the delivery of the devices and cartridges was discussed. The other partners presented and discussed the results of their prototype tests during the past 5 months.

The WEAKID team that was present, from left to right:

Abelardo Aguilera (IdiPAZ)
Rafael Selgas (IdiPAZ)
Maria Bajo (IdiPAZ)
Sander Onur (UMCU)
Maaike van Gelder (UMCU)
Karin Gerritsen (UMCU)
Marlies van Dullemen (UMCU)
Frank Simonis (Nanodialysis)
Giulia Ligabue (UNIMORE)
Gianni Cappelli (UNIMORE)
Francesco Fontana (UNIMORE)
Maarten Simonis (Nanodialysis)


















In the afternoon the members of the ethical board were welcomed. UMCU presented the clinical protocol and a list of ethical considerations has been discussed. The ethical board of WEAKID consists of the following members:

dr. Fernando Garcia-Lopez (ISCIII, Es)
prof. Ciro Tetta (University of Turin, It)
prof. Inez de Beaufort (Erasmus University, NL)
dr. Eline Bunnink (Erasmus University, NL)


WEAKID    PROTOTYPE   TESTING  26-28 April 2017
Prototype versions of the WEAKID device have been tested at University UNIMORE in Modena on April 26 & 28. The tests are aimed to validate the efficacy (clearance) and biocompatibility of the device prior to the clinical trials.


WEAKID    PROTOTYPE   TESTING  13-14 March 2017
Prototype versions of the WEAKID device have been tested at Hospital Universitario La Paz (IdiPAZ) in Madrid on March 13 & 14. The tests are aimed to validate the efficacy (clearance) and biocompatibility of the device prior to the clinical trials.


WEAKID    KICK OFF MEETING    16-17 January 2017

The kick-off meeting of the WEAKID project has been held at UMCU on January 16 & 17 2017.


















No comments:

Post a Comment